Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H15N |
| Molecular Weight | 101.19 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC
InChI
InChIKey=ZMANZCXQSJIPKH-UHFFFAOYSA-N
InChI=1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3
| Molecular Formula | C6H15N |
| Molecular Weight | 101.19 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1.17 μM |
25 mg single, oral dose: 25 mg route of administration: Oral experiment type: SINGLE co-administered: |
TRIETHYLAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
3.81 μM × h |
137 μmol single, intravenous dose: 137 μmol route of administration: Intravenous experiment type: SINGLE co-administered: |
TRIETHYLAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
5.46 μM × h |
25 mg single, oral dose: 25 mg route of administration: Oral experiment type: SINGLE co-administered: |
TRIETHYLAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
3.7 h |
137 μmol single, intravenous dose: 137 μmol route of administration: Intravenous experiment type: SINGLE co-administered: |
TRIETHYLAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
2.9 h |
25 mg single, oral dose: 25 mg route of administration: Oral experiment type: SINGLE co-administered: |
TRIETHYLAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography. | 2001 |
|
| Cell adhesion and signaling on the fibronectin 1st type III repeat; requisite roles for cell surface proteoglycans and integrins. | 2001 |
|
| Simultaneous analysis of clozapine, clomipramine and their metabolites by reversed-phase liquid chromatography. | 2001 Apr |
|
| The rapid quantitative analysis of phenprobamate and acetaminophen by RP-LC and compensation technique. | 2001 Apr |
|
| High-performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations. | 2001 Apr 15 |
|
| Synthesis of TiRru2 heterobimetallic and TiRuM (M = Rh, Rr, Pd, Pt) heterotrimetallic sulfido clusters from a hydrosulfido-bridged titanium-ruthenium complex. | 2001 Apr 23 |
|
| Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection. | 2001 Dec |
|
| Quality of odor and olfactory lateralization processes in humans. | 2001 Dec |
|
| Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. | 2001 Jan |
|
| Spectrophotometric measurement of mercaptans with 4,4'-dithiodipyridine. | 2001 Jan 15 |
|
| An expedient route to 2,3-substituted and fused benzo[a]quinolizine-4-thione framework via ring annulation with beta-oxodithioesters. | 2001 Jan 25 |
|
| Analysis of phospholipid species in human blood using normal-phase liquid chromatography coupled with electrospray ionization ion-trap tandem mass spectrometry. | 2001 Jul 15 |
|
| A novel mechanical dissociation technique for studying acutely isolated maturing Drosophila central neurons. | 2001 Jul 30 |
|
| Electronic structure of bis(o-iminobenzosemiquinonato)metal complexes (Cu, Ni, Pd). The art of establishing physical oxidation states in transition-metal complexes containing radical ligands. | 2001 Mar 14 |
|
| Development of liquid chromatographic method for the analysis of kanamycin residues in varicella vaccine using phenylisocyanate as a derivatization reagent. | 2001 Mar 5 |
|
| Fluorescent labeling of drugs and simple organic compounds containing amine functional groups, utilizing dansyl chloride in Na(2)CO(3) buffer. | 2001 May-Jun |
|
| Analysis of polymerase chain reaction products by on-line liquid chromatography-mass spectrometry for genotyping of polymorphic short tandem repeat loci. | 2001 Nov 1 |
|
| Impact of triethylamine as a mobile phase additive on the resolution of racemic amino acids on an (+)-18-crown-6-tetracarboxylic acid-derived chiral stationary phase. | 2001 Nov 9 |
|
| Development of sensitive high-performance liquid chromatography with fluorescence detection using 4-(4,5-diphenyl-1H-imidazol-2-yl)-benzoyl chloride as a labeling reagent for determination of bisphenol A in plasma samples. | 2001 Oct 5 |
|
| The aquatic fate of triclopyr in whole-pond treatments. | 2001 Sep |
|
| Assessment of the retention properties of poly(vinyl alcohol) stationary phase for lipid class profiling in liquid chromatography. | 2001 Sep 14 |
|
| Simultaneous determination of ingredients in an ointment by hydrophobic interaction electrokinetic chromatography. | 2001 Sep 21 |
|
| Quantification of metronidazole in small-volume biological samples using narrow-bore high-performance liquid chromatography. | 2001 Sep 25 |
|
| Quantification of epimeric budesonide and fluticasone propionate in human plasma by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. | 2001 Sep 25 |
|
| Not all 'predator odours' are equal: cat odour but not 2,4,5 trimethylthiazoline (TMT; fox odour) elicits specific defensive behaviours in rats. | 2002 Feb 1 |
|
| Mechanism of response enhancement in evaporative light scattering detection with the addition of triethylamine and formic acid. | 2002 Jan |
|
| Excited state proton transfer reaction of two new intramolecularly hydrogen bonded Schiff bases at room temperature and 77K. | 2002 Jan 1 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:12 UTC 2023
by
admin
on
Fri Dec 15 15:11:12 UTC 2023
|
| Record UNII |
VOU728O6AY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
TRIETHYLAMINE
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000156649
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
VOU728O6AY
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
204-469-4
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
896
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
1307097
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | RxNorm | ||
|
8471
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
C016162
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
TRIETHYLAMINE
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
121-44-8
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
35026
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
VOU728O6AY
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
SUB130556
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
DTXSID3024366
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
1683559
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
1600
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | |||
|
m11101
Created by
admin on Fri Dec 15 15:11:12 UTC 2023 , Edited by admin on Fri Dec 15 15:11:12 UTC 2023
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
